PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
+34.82%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$11.6B
AUM Growth
+$2.27B
(+24%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-1.2%
Top 10 Holdings %
Top 10 Hldgs %
30.27%
Holding
350
New
64
Increased
74
Reduced
125
Closed
73
Top Buys
| 1 |
PayPal
PYPL
|
$133M |
| 2 |
Meta Platforms (Facebook)
META
|
$115M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
$110M |
| 4 |
UnitedHealth
UNH
|
$110M |
| 5 |
Ciena
CIEN
|
$94M |
Top Sells
| 1 |
AbbVie
ABBV
|
$85.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
$83.2M |
| 3 |
Amazon
AMZN
|
$83M |
| 4 |
Intel
INTC
|
$72.3M |
| 5 |
RingCentral
RNG
|
$71.8M |
Sector Composition
| 1 | Technology | 36.18% |
| 2 | Healthcare | 19.13% |
| 3 | Financials | 17.17% |
| 4 | Communication Services | 12.96% |
| 5 | Consumer Discretionary | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Insmed
INSM
$30B
| $12.7M | 0.11% |
460,350
-39,650
| -8% | -$1.09M |
|
152
Kulicke & Soffa
KLIC
$1.96B
| $12.2M | 0.11% |
+584,907
| New | +$12.2M |
|
153
Accenture
ACN
$157B
| $12.1M | 0.1% |
56,325
-56,509
| -50% | -$12.1M |
|
154
Cytokinetics
CYTK
$6.01B
| $11.8M | 0.1% |
+500,000
| New | +$11.8M |
|
155
Affiliated Managers Group
AMG
$6.59B
| $11.7M | 0.1% |
156,854
-127,194
| -45% | -$9.48M |
|
156
Alnylam Pharmaceuticals
ALNY
$59.4B
| $11.1M | 0.1% |
75,000
-75,000
| -50% | -$11.1M |
|
157
Amgen
AMGN
$151B
| $11.1M | 0.1% |
+47,081
| New | +$11.1M |
|
|
GBT
158
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11M | 0.1% |
+175,000
| New | +$11M |
|
159
Sabre
SABR
$675M
| $11M | 0.1% |
+1,366,611
| New | +$11M |
|
160
Neurocrine Biosciences
NBIX
$13.7B
| $11M | 0.09% |
89,878
-15,982
| -15% | -$1.95M |
|
161
uniQure
QURE
$957M
| $10.5M | 0.09% |
233,298
+29,800
| +15% | +$1.34M |
|
|
VAR
162
DELISTED
Varian Medical Systems, Inc.
VAR
| $10.4M | 0.09% |
85,012
-369,812
| -81% | -$45.3M |
|
163
Tesla
TSLA
$1.08T
| $10.3M | 0.09% |
143,730
+57,135
| +66% | +$4.11M |
|
164
ProAssurance
PRA
$1.22B
| $10.1M | 0.09% |
700,000
| – | – |
|
|
MYOK
165
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $9.91M | 0.09% |
+102,585
| New | +$9.91M |
|
166
LivePerson
LPSN
$88.8M
| $9.79M | 0.08% |
+236,225
| New | +$9.79M |
|
|
MRTX
167
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.7M | 0.08% |
85,000
-15,000
| -15% | -$1.71M |
|
168
TE Connectivity
TEL
$61.5B
| $9.45M | 0.08% |
+115,842
| New | +$9.45M |
|
|
XLRN
169
DELISTED
Acceleron Pharma Inc.
XLRN
| $9.34M | 0.08% |
98,078
+23,078
| +31% | +$2.2M |
|
170
Replimune Group
REPL
$453M
| $9.32M | 0.08% |
375,000
+125,000
| +50% | +$3.11M |
|
|
DCPH
171
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $8.96M | 0.08% |
150,000
-466,261
| -76% | -$27.8M |
|
172
HCA Healthcare
HCA
$96.5B
| $8.6M | 0.07% |
88,562
-444,865
| -83% | -$43.2M |
|
173
Bandwidth Inc
BAND
$469M
| $8.39M | 0.07% |
66,087
-17,093
| -21% | -$2.17M |
|
174
Texas Instruments
TXN
$171B
| $8.32M | 0.07% |
65,512
-119,261
| -65% | -$15.1M |
|
|
APTO
175
DELISTED
Aptose Biosciences, Inc.
APTO
| $8.06M | 0.07% |
2,840
-4,269
| -60% | -$12.1M |
|